Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 577 (ZNF577) is a member of the zinc finger protein family, characterized by the presence of C2H2-type zinc finger motifs involved in binding DNA and regulating gene expression. ZNF577’s biological function has not been fully elucidated; however, it is thought to act as a transcription factor like other members of the zinc finger protein family[1][2]. Recent evidence has linked hypermethylation and decreased expression of ZNF577 to poorer clinical outcomes in lung adenocarcinoma, suggesting its potential utility as a prognostic biomarker[3]. There are no known drugs targeting ZNF577, nor are there confirmed mechanisms of drug action or specific safety concerns associated with therapeutic modulation of this protein. The precise role of ZNF577 in normal physiology and disease remains a topic of ongoing research[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 577 (ZNF577).